Neogenomics
NeoGenomics Acquires Clinical Lab Pathline
NeoGenomics said that the acquisition will help it expand its footprint in the Northeastern US.
360Dx Top 30 Drops 9 Percent in February
Of the 30 companies on the list, 22 firms saw their share prices decline month over month, while eight companies saw their stock prices rise.
NeoGenomics Q4 Revenues up 11 Percent, Miss Analyst Estimates
Fourth quarter revenues of $172 million fell short of analysts' average expectations, but the company saw a boost in volume and average billing driven by a push toward higher-value tests.
360Dx Top 30 Rockets 10 Percent in January
Of the 30 companies included, 19 companies saw their stock price increase, eight firms saw their share price decrease, and three companies remained essentially flat.
Although the firm did not provide preliminary financial results for 2024, CEO Chris Smith reaffirmed previous guidance of revenues between $655 million and $667 million.